Get started
Author

Alex Wheatcroft

Observed names: ALEX WHEATCROFT, Wheatcroft, Alex
OpenAlex ID: A5076884949
Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level
2025 · Irl B. Hirsch, Yogish C. Kudva, et al. · Diabetes Care · 8
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes
2025 · Timothy E. Graham, Dan Raghinaru, et al. · Diabetes Care · 3
PDF
761-P: Long-Term Glycemic Control in Adult Participants Using Control-IQ Technology: Real-World Evidence
2022 · RISHI GRAHAM, HARSIMRAN SINGH, et al. · Diabetes · 2
Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies
2025 · Roy W. Beck, Irl B. Hirsch, et al. · Diabetes Care · 1
PDF
Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology
2024 · Viral N. Shah, Halis K. Akturk, et al. · Journal of Diabetes Science and Technology · 1
PDF
281-OR: Psychosocial Benefits of Using Control-IQ Technology: Long-Term Outcomes from a Multiethnic Adult Cohort with Type 1 Diabetes
2022 · HARSIMRAN SINGH, GABRIEL ALENCAR, et al. · Diabetes · 1
792-P: Evaluation of Long-Term Glycemic Outcomes by Ethnicity in Adults with Type 1 Diabetes Using Control-IQ Technology
2022 · RISHI GRAHAM, HARSIMRAN SINGH, et al. · Diabetes · 1
1893-P: High Parental Satisfaction and Enhanced Quality of Life with Tandem Control-IQ+ in Very Young Children
2026 · CHARLES S. RUMSEY, RISHI GRAHAM, et al. · Diabetes
929-P: Adaptive Therapy Settings—Qualitative Insights from People with Type 1 Diabetes Using Multiple Daily Injections Transitioning to an Automated System
2023 · STEPHANIE HABIF, ELAINE SCHERTZ, et al. · Diabetes
Works count: 13
Citation count: 17
H-index: 2
I10-index:
Year
Topic
Type